StepStone Group’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.61M Hold
761,277
4.63% 7
2025
Q4
$7.83M Hold
761,277
4.19% 5
2025
Q3
$4.42M Hold
761,277
2.08% 8
2025
Q2
$5.12M Hold
761,277
10.14% 4
2025
Q1
$6.88M Hold
761,277
7.07% 4
2024
Q4
$13.2M Hold
761,277
11.51% 3
2024
Q3
$12.2M Hold
761,277
4.44% 7
2024
Q2
$10.8M Hold
761,277
2.2% 8
2024
Q1
$10.8M Hold
761,277
2.29% 8
2023
Q4
$11.5M Hold
761,277
2.07% 8
2023
Q3
$12M Hold
761,277
2.68% 7
2023
Q2
$11.5M Hold
761,277
2.13% 7
2023
Q1
$11M Hold
761,277
2.05% 7
2022
Q4
$10.3M Hold
761,277
1.34% 12
2022
Q3
$12M Buy
761,277
+126,318
+20% +$1.6M 1.71% 10
2022
Q2
$7.73M Sell
634,959
-126,318
-17% -$958K 0.83% 15
2022
Q1
$7.15M Hold
761,277
0.53% 14
2021
Q4
$13M Buy
+761,277
New +$18.5M 0.74% 13

Other funds holding TRDA